{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:59:06Z","timestamp":1792630746653,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:00:00Z","timestamp":1729123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:00:00Z","timestamp":1729123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Anesth Analg Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Perioperative adrenergic vasopressors in kidney transplantation have been linked to negative outcomes and arrhythmias. Synthetic angiotensin II (AT2S) could improve renal hemodynamics, preserve allograft function, and reduce arrhythmias.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>We aimed to compare the effectiveness and safety of AT2S to adrenergic vasopressors when used for perioperative hypotension in kidney transplant.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This single-center, retrospective cohort study included adults with perioperative shock requiring AT2S or adrenergic agents as first-line vasopressors during kidney transplant. The primary outcome was the need for a second continuous infusion vasopressor agents beyond the first-line agent. Secondary outcomes assessed adverse events and early allograft outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Twenty patients receiving AT2S and 60 patients receiving adrenergic vasopressor agents were included. Intraoperatively, 1 of 20 patients (5%) in the AT2S group needed a second continuous vasopressor compared to 7 of 60 patients (11.7%) who needed a second continuous vasopressor in the adrenergic vasopressor group (<jats:italic>P<\/jats:italic>\u2009=\u20090.672). Postoperatively, 1 of 20 patients (5%) in the AT2S group compared to 12 of 60 patients (20%) in the adrenergic vasopressor group required a second vasopressor (<jats:italic>P<\/jats:italic>\u2009=\u20090.168). There were significantly fewer arrhythmias (1\/20 [5%] vs. 17\/60 [28.3%]), <jats:italic>P<\/jats:italic>\u2009=\u20090.03) and ischemic complications (0\/20 [0%] vs. 11\/20 [18.3%], <jats:italic>P<\/jats:italic>\u2009=\u20090.031) in patients who received AT2S. There were no differences in immediate, slow, or delayed graft function or in discharge, 1-month, and 3-month glomerular filtration rates (p\u2009&gt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion\u00a0and Relevance<\/jats:title>\n                <jats:p>Both AT2S and adrenergic vasopressors are effective for perioperative hypotension in kidney transplant, with AT2S showing a lower incidence of arrhythmias and ischemic complications.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s44158-024-00207-w","type":"journal-article","created":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T16:03:03Z","timestamp":1729180983000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A retrospective cohort analysis comparing the effectiveness and safety of perioperative angiotensin II to adrenergic vasopressors as a first-line vasopressor in kidney transplant recipients"],"prefix":"10.1186","volume":"4","author":[{"given":"George","family":"Urias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Benken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hokuto","family":"Nishioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Benedetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott T.","family":"Benken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,17]]},"reference":[{"issue":"2","key":"207_CR1","doi-asserted-by":"publisher","first-page":"174","DOI":"10.4103\/0970-9185.155144","volume":"31","author":"NK Aulakh","year":"2015","unstructured":"Aulakh NK, Garg K, Bose A, Aulakh BS, Chahal HS, Aulakh GS (2015) Influence of hemodynamics and intra-operative hydration on biochemical outcome of renal transplant recipients. J Anaesthesiol Clin Pharmacol. 31(2):174\u20139. https:\/\/doi.org\/10.4103\/0970-9185.155144","journal-title":"J Anaesthesiol Clin Pharmacol."},{"issue":"6","key":"207_CR2","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1016\/j.transproceed.2012.05.042","volume":"44","author":"L Campos","year":"2012","unstructured":"Campos L, Parada B, Furriel F, Castelo D, Moreira P, Mota A (2012) Do intraoperative hemodynamic factors of the recipient influence renal graft function? Transplant Proc. 44(6):1800\u20133. https:\/\/doi.org\/10.1016\/j.transproceed.2012.05.042","journal-title":"Transplant Proc."},{"issue":"2","key":"207_CR3","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/00000658-198502000-00020","volume":"201","author":"RG Tiggeler","year":"1985","unstructured":"Tiggeler RG, Berden JH, Hoitsma AJ, Koene RA (1985) Prevention of acute tubular necrosis in cadaveric kidney transplantation by the combined use of mannitol and moderate hydration. Ann Surg 201(2):246\u2013251. https:\/\/doi.org\/10.1097\/00000658-198502000-00020","journal-title":"Ann Surg"},{"issue":"7","key":"207_CR4","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1097\/00003246-198707000-00001","volume":"15","author":"I Dawidson","year":"1987","unstructured":"Dawidson I, Berglin E, Brynger H, Reisch J (1987) Intravascular volumes and colloid dynamics in relation to fluid management in living related kidney donors and recipients. Crit Care Med. 15(7):631\u2013636. https:\/\/doi.org\/10.1097\/00003246-198707000-00001","journal-title":"Crit Care Med."},{"issue":"1","key":"207_CR5","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005820","volume":"96","author":"JM Choi","year":"2017","unstructured":"Choi JM, Jo JY, Baik JW, Kim S, Kim CS, Jeong SM (2017) Risk factors and outcomes associated with a higher use of inotropes in kidney transplant recipients. Medicine 96(1):e5820. https:\/\/doi.org\/10.1097\/MD.0000000000005820","journal-title":"Medicine"},{"issue":"9","key":"207_CR6","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.14754","volume":"36","author":"L Andrews","year":"2022","unstructured":"Andrews L, Benken J, Benedetti E et al (2022) Effects of angiotensin II in the management of perioperative hypotension in kidney transplant recipients. Clin Transplant 36(9):e14754. https:\/\/doi.org\/10.1111\/ctr.14754","journal-title":"Clin Transplant"},{"issue":"4","key":"207_CR7","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.jcrc.2010.02.011","volume":"25","author":"R Robert","year":"2010","unstructured":"Robert R, Guilhot J, Pinsard M et al (2010) A pair analysis of the delayed graft function in kidney recipient: the critical role of the donor. J Crit Care 25(4):582\u2013590. https:\/\/doi.org\/10.1016\/j.jcrc.2010.02.011","journal-title":"J Crit Care"},{"issue":"10","key":"207_CR8","doi-asserted-by":"publisher","first-page":"4165","DOI":"10.1016\/j.transproceed.2009.08.058","volume":"41","author":"M Ciapetti","year":"2009","unstructured":"Ciapetti M, di Valvasone S, di Filippo A, Cecchi A, Bonizzoli M, Peris A (2009) Low-dose dopamine in kidney transplantation. Transplant Proc 41(10):4165\u20134168. https:\/\/doi.org\/10.1016\/j.transproceed.2009.08.058","journal-title":"Transplant Proc"},{"issue":"6","key":"207_CR9","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.jamcollsurg.2014.01.058","volume":"218","author":"KM Day","year":"2014","unstructured":"Day KM, Beckman RM, Machan JT, Morrissey PE (2014) Efficacy and safety of phenylephrine in the management of low systolic blood pressure after renal transplantation. J Am Coll Surg 218(6):1207\u20131213. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2014.01.058","journal-title":"J Am Coll Surg"},{"issue":"1","key":"207_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13613-015-0085-5","volume":"5","author":"R Kato","year":"2015","unstructured":"Kato R, Pinsky MR (2015) Personalizing blood pressure management in septic shock. Ann Intensive Care 5(1):41. https:\/\/doi.org\/10.1186\/s13613-015-0085-5","journal-title":"Ann Intensive Care"},{"issue":"5","key":"207_CR11","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.semnephrol.2019.06.006","volume":"39","author":"LW Busse","year":"2019","unstructured":"Busse LW, Ostermann M (2019) Vasopressor Therapy and Blood Pressure Management in the Setting of Acute Kidney Injury. Semin Nephrol 39(5):462\u2013472. https:\/\/doi.org\/10.1016\/j.semnephrol.2019.06.006","journal-title":"Semin Nephrol"},{"issue":"1","key":"207_CR12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.kint.2018.10.009","volume":"95","author":"SF Smith","year":"2019","unstructured":"Smith SF, Hosgood SA, Nicholson ML (2019) Ischemia-reperfusion injury in renal transplantation: 3 key signaling pathways in tubular epithelial cells. Kidney Int 95(1):50\u201356. https:\/\/doi.org\/10.1016\/j.kint.2018.10.009","journal-title":"Kidney Int"},{"issue":"2","key":"207_CR13","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/00000658-200008000-00017","volume":"232","author":"J Pratschke","year":"2000","unstructured":"Pratschke J, Wilhelm MJ, Kusaka M et al (2000) Accelerated rejection of renal allografts from brain-dead donors. Ann Surg 232(2):263\u2013271. https:\/\/doi.org\/10.1097\/00000658-200008000-00017","journal-title":"Ann Surg"},{"issue":"1","key":"207_CR14","first-page":"78","volume":"9","author":"J Pratschke","year":"2004","unstructured":"Pratschke J, Tullius SG, Neuhaus P (2004) Brain death associated ischemia\/reperfusion injury. Ann Transplant 9(1):78\u201380","journal-title":"Ann Transplant"},{"key":"207_CR15","doi-asserted-by":"publisher","unstructured":"Gombos EA, HULET WH, BOPP P, GOLDRINGW, BALDWIN DS, CHASIS kidney transplant. Reactivity of renal and systemic circulations to vasoconstrictor agents in normotensive and hypertensive subjects. J Clin Invest. 1962;41(2):203\u2013217.\u00a0 https:\/\/doi.org\/10.1172\/JCI104472.","DOI":"10.1172\/JCI104472"},{"key":"207_CR16","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1152\/ajplegacy.1960.198.6.1279","volume":"198","author":"LC Mills","year":"1960","unstructured":"Mills LC, Moyer JH, Handley CA (1960) Effects of various sympathicomimetic drugs on renal hemodynamics in normotensive and hypotensive dogs. Am J Physiol 198:1279\u20131283. https:\/\/doi.org\/10.1152\/ajplegacy.1960.198.6.1279","journal-title":"Am J Physiol"},{"issue":"7","key":"207_CR17","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1097\/00003246-199607000-00014","volume":"24","author":"M Richer","year":"1996","unstructured":"Richer M, Robert S, Lebel M (1996) Renal hemodynamics during norepinephrine and low-dose dopamine infusions in man. Crit Care Med 24(7):1150\u20131156. https:\/\/doi.org\/10.1097\/00003246-199607000-00014","journal-title":"Crit Care Med"},{"issue":"9","key":"207_CR18","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1097\/CCM.0000000000006314","volume":"52","author":"F D'Amico","year":"2024","unstructured":"D\u2019Amico F, Pruna A, Putowski Z, Dormio S, Ajello S, Scandroglio AM, Lee TC, Zangrillo A, Landoni G (2024) Low Versus High Blood Pressure Targets in Critically Ill and Surgical Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Crit Care Med 52(9):1427\u20131438. https:\/\/doi.org\/10.1097\/CCM.0000000000006314","journal-title":"Crit Care Med"},{"key":"207_CR19","doi-asserted-by":"publisher","unstructured":"Benken J, Lichvar A, Benedetti E, et al. Perioperative Vasopressors are Associated with Delayed Graft Function in Kidney Transplant Recipients in a Primarily Black and Hispanic Cohort. Prog Transplant. Published online April 28, 2022:15269248221087432. https:\/\/doi.org\/10.1177\/15269248221087433","DOI":"10.1177\/15269248221087433"},{"key":"207_CR20","unstructured":"Angiotensin II (Giapreza) [package insert]. LaJolla (CA): Innoviva Pharmaceuticals; published online 2017."},{"key":"207_CR21","first-page":"665","volume-title":"Quantitative Human Physiology","author":"F Joseph","year":"2012","unstructured":"Joseph F (2012) Regulation of Fluid and Electrolyte Balance. In: Fehrer J (ed) Quantitative Human Physiology, 1st edn. Elsevier Publishing, pp 665\u2013673","edition":"1"},{"issue":"18","key":"207_CR22","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1001\/jama.2018.4528","volume":"319","author":"WF McIntyre","year":"2018","unstructured":"McIntyre WF, Um KJ, Alhazzani W et al (2018) Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock: A Systematic Review and Meta-analysis. JAMA. 319(18):1889\u20131900. https:\/\/doi.org\/10.1001\/jama.2018.4528","journal-title":"JAMA."},{"issue":"5","key":"207_CR23","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1056\/NEJMoa1704154","volume":"377","author":"A Khanna","year":"2017","unstructured":"Khanna A, English SW, Wang XS et al (2017) Angiotensin II for the Treatment of Vasodilatory Shock. N Engl J Med 377(5):419\u2013430. https:\/\/doi.org\/10.1056\/NEJMoa1704154","journal-title":"N Engl J Med"},{"issue":"8","key":"207_CR24","doi-asserted-by":"publisher","first-page":"e15432","DOI":"10.1111\/ctr.15432","volume":"38","author":"LP Beltran","year":"2024","unstructured":"Beltran LP, Benken J, Jou J, Benedetti E, Nishioka H, Alamreia E, Belcher RM, Benken ST (2024Aug) Efficacy and Safety of Perioperative Angiotensin II Versus Phenylephrine as a First-Line Continuous Infusion Vasopressor in Kidney Transplant Recipients. Clin Transplant 38(8):e15432","journal-title":"Clin Transplant"},{"issue":"1","key":"207_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13054-023-04322-y","volume":"27","author":"Y Kotani","year":"2023","unstructured":"Kotani Y, Di Gioia A, Landoni G, Belletti A, Khanna AK (2023J 20) An updated \u201cnorepinephrine equivalent\u201d score in intensive care as a marker of shock severity. Crit Care 27(1):29. https:\/\/doi.org\/10.1186\/s13054-023-04322-y","journal-title":"Crit Care"},{"issue":"11","key":"207_CR26","doi-asserted-by":"publisher","first-page":"e078713","DOI":"10.1136\/bmjopen-2023-078713","volume":"13","author":"MP Bokoch","year":"2023","unstructured":"Bokoch MP, Tran AT, Brinson EL et al (2023) Angiotensin II in liver transplantation (AngLT-1): protocol of a randomised, double-blind, placebo-controlled trial. BMJ Open 13(11):e078713","journal-title":"BMJ Open"},{"key":"207_CR27","doi-asserted-by":"crossref","unstructured":"Running K, Weinberg D, Trudo W, Sullivan CL, Patel GP (2021) Intraoperative Use of Angiotensin II for Severe Vasodilatory Shock During Liver Transplantation: A Case Report. A A Pract. 15(2):e01402. https:\/\/doi.org\/10.1213\/XAA.0000000000001402.","DOI":"10.1213\/XAA.0000000000001402"},{"issue":"9","key":"207_CR28","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1053\/j.jvca.2020.07.087","volume":"35","author":"NS Cutler","year":"2021","unstructured":"Cutler NS, Rasmussen BM, Bredeck JF, Lata AL, Khanna AK (2021) Angiotensin II for Critically Ill Patients With Shock After Heart Transplant. J Cardiothorac Vasc Anesth 35(9):2756\u20132762. https:\/\/doi.org\/10.1053\/j.jvca.2020.07.087","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"4","key":"207_CR29","doi-asserted-by":"publisher","first-page":"98","DOI":"10.14797\/mdcvj.576","volume":"17","author":"W Sovic","year":"2021","unstructured":"Sovic W, Mathew C, Blough B et al (2021) Angiotensin II: A Multimodal Approach to Vasoplegia in a Cardiac Setting. Methodist Debakey Cardiovasc J. 17(4):98\u2013101. https:\/\/doi.org\/10.14797\/mdcvj.576","journal-title":"Methodist Debakey Cardiovasc J."},{"issue":"4","key":"207_CR30","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/cc8224","volume":"15","author":"JA Russell","year":"2011","unstructured":"Russell JA (2011) Bench-to-bedside review: Vasopressin in the management of septic shock. Crit Care 15(4):226. https:\/\/doi.org\/10.1186\/cc8224","journal-title":"Crit Care"},{"issue":"2","key":"207_CR31","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1152\/ajprenal.1989.256.2.F274","volume":"256","author":"RM Edwards","year":"1989","unstructured":"Edwards RM, Trizna W, Kinter LB (1989) Renal microvascular effects of vasopressin and vasopressin antagonists. Am J Physiol. 256(2):274\u20138. https:\/\/doi.org\/10.1152\/ajprenal.1989.256.2.F274","journal-title":"Am J Physiol."},{"issue":"5","key":"207_CR32","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1001\/jama.2016.10485","volume":"316","author":"AC Gordon","year":"2016","unstructured":"Gordon AC, Mason AJ, Thirunavukkarasu N et al (2016) Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial. JAMA 316(5):509\u2013518. https:\/\/doi.org\/10.1001\/jama.2016.10485","journal-title":"JAMA"},{"issue":"4","key":"207_CR33","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1053\/j.jvca.2011.04.007","volume":"25","author":"MJ Andritsos","year":"2011","unstructured":"Andritsos MJ (2011) Con: methylene blue should not be used routinely for vasoplegia perioperatively. J Cardiothorac Vasc Anesth 25(4):739\u2013743. https:\/\/doi.org\/10.1053\/j.jvca.2011.04.007","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"4","key":"207_CR34","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.transproceed.2020.09.019","volume":"53","author":"D Weinberg","year":"2021","unstructured":"Weinberg D, Running K, Kalarickal PL, Patel GP (2021) Use of Intravenous Hydroxocobalamin for Vasoplegic Syndrome in Simultaneous Liver-Kidney Transplant: A Case Report. Transplant Proc 53(4):1300\u20131302. https:\/\/doi.org\/10.1016\/j.transproceed.2020.09.019","journal-title":"Transplant Proc"},{"issue":"1","key":"207_CR35","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1053\/j.jvca.2023.09.037","volume":"38","author":"A Pruna","year":"2024","unstructured":"Pruna A, Bonaccorso A, Belletti A, Turi S, Di Prima AL, D\u2019amico F, Zangrillo A, Kotani Y, Landoni G (2024J) Methylene Blue Reduces Mortality in Critically Ill and Perioperative Patients: A Meta-Analysis of Randomized Trials. J Cardiothorac Vasc Anesth 38(1):268\u2013274. https:\/\/doi.org\/10.1053\/j.jvca.2023.09.037","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"207_CR36","doi-asserted-by":"publisher","first-page":"107488","DOI":"10.1016\/j.ijscr.2022.107488","volume":"98","author":"BT Boettcher","year":"2022","unstructured":"Boettcher BT, Woehlck HJ, Makker H, Pagel PS, Freed JK (2022) Hydroxocobalamin for treatment of catecholamine-resistant vasoplegia during liver transplantation: A single-center series of 20 cases. Int J Surg Case Rep. 98:107488.\u00a0https:\/\/doi.org\/10.1016\/j.ijscr.2022.107488","journal-title":"Int J Surg Case Rep."},{"key":"207_CR37","doi-asserted-by":"publisher","unstructured":"Stangl M, Zerkaulen T, Theodorakis J, et al. Influence of brain death on cytokine release in organ donors and renal transplants. Transplant Proc. 33(1\u20132):1284\u20131285. https:\/\/doi.org\/10.1016\/s0041-1345(00)02479-9","DOI":"10.1016\/s0041-1345(00)02479-9"},{"key":"207_CR38","doi-asserted-by":"publisher","unstructured":"Brennan T v, Lunsford KE, Kuo PC. Innate pathways of immune activation in transplantation. J Transplant. 2010;2010. https:\/\/doi.org\/10.1155\/2010\/826240","DOI":"10.1155\/2010\/826240"},{"issue":"4","key":"207_CR39","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1034\/j.1600-6143.2003.00071.x","volume":"3","author":"KC Abbott","year":"2003","unstructured":"Abbott KC, Reynolds JC, Taylor AJ, Agodoa LY (2003) Hospitalized atrial fibrillation after renal transplantation in the United States. Am J Transplant 3(4):471\u2013476. https:\/\/doi.org\/10.1034\/j.1600-6143.2003.00071.x","journal-title":"Am J Transplant"},{"issue":"2","key":"207_CR40","doi-asserted-by":"publisher","first-page":"288","DOI":"10.2215\/CJN.00920805","volume":"1","author":"KL Lentine","year":"2006","unstructured":"Lentine KL, Schnitzler MA, Abbott KC et al (2006) Incidence, predictors, and associated outcomes of atrial fibrillation after kidney transplantation. Clin J Am Soc Nephrol 1(2):288\u2013296. https:\/\/doi.org\/10.2215\/CJN.00920805","journal-title":"Clin J Am Soc Nephrol"},{"issue":"20","key":"207_CR41","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1056\/NEJM199705153362006","volume":"336","author":"SR Ommen","year":"1997","unstructured":"Ommen SR, Odell JA, Stanton MS (1997) Atrial arrhythmias after cardiothoracic surgery. N Engl J Med 336(20):1429\u20131434. https:\/\/doi.org\/10.1056\/NEJM199705153362006","journal-title":"N Engl J Med"},{"issue":"9","key":"207_CR42","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1056\/NEJMoa0907118","volume":"362","author":"D De Backer","year":"2010","unstructured":"De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, Brasseur A, Defrance P, Gottignies P, Vincent JL (2010M 4) Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 362(9):779\u2013789","journal-title":"N Engl J Med"},{"key":"207_CR43","unstructured":"VanValkinburgh D, Kerndt CC, Hashmi MF. Inotropes and Vasopressors. [Updated 2023 Feb 19]. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK482411\/"},{"issue":"1","key":"207_CR44","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13054-022-03960-y","volume":"26","author":"R Suzuki","year":"2022","unstructured":"Suzuki R, Uchino S, Sasabuchi Y, Kawarai Lefor A, Sanui M (2022A 2) Dopamine use and its consequences in the intensive care unit: a cohort study utilizing the Japanese Intensive care PAtient Database. Crit Care 26(1):90","journal-title":"Crit Care"},{"issue":"10","key":"207_CR45","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1111\/j.1600-6143.2010.03179.x","volume":"10","author":"WD Irish","year":"2010","unstructured":"Irish WD, Ilsley JN, Schnitzler MA, Feng S, Brennan DC (2010) A risk prediction model for delayed graft function in the current era of deceased donor renal transplantation. Am J Transplant 10(10):2279\u20132286. https:\/\/doi.org\/10.1111\/j.1600-6143.2010.03179.x","journal-title":"Am J Transplant"},{"issue":"1","key":"207_CR46","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1097\/CCM.0000000000002797","volume":"46","author":"YR Lankadeva","year":"2018","unstructured":"Lankadeva YR, Kosaka J, Evans RG, Bellomo R, May CN (2018) Urinary Oxygenation as a Surrogate Measure of Medullary Oxygenation During Angiotensin II Therapy in Septic Acute Kidney Injury. Crit Care Med 46(1):e41\u2013e48. https:\/\/doi.org\/10.1097\/CCM.0000000000002797","journal-title":"Crit Care Med"},{"issue":"6","key":"207_CR47","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1097\/CCM.0000000000003092","volume":"46","author":"JA Tumlin","year":"2018","unstructured":"Tumlin JA, Murugan R, Deane AM et al (2018) Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II. Crit Care Med 46(6):949\u2013957. https:\/\/doi.org\/10.1097\/CCM.0000000000003092","journal-title":"Crit Care Med"},{"issue":"6","key":"207_CR48","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1111\/ajt.12197","volume":"13","author":"CR Lenihan","year":"2013","unstructured":"Lenihan CR, Montez-Rath ME, Scandling JD, Turakhia MP, Winkelmayer WC (2013) Outcomes after kidney transplantation of patients previously diagnosed with atrial fibrillation. Am J Transplant 13(6):1566\u20131575. https:\/\/doi.org\/10.1111\/ajt.12197","journal-title":"Am J Transplant"},{"issue":"3","key":"207_CR49","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1177\/106002809502900309","volume":"29","author":"JE Tisdale","year":"1995","unstructured":"Tisdale JE, Patel RV, Webb CR, Borzak S, Zarowitz BJ (1995) Proarrhythmic effects of intravenous vasopressors. Ann Pharmacother 29(3):269\u2013281. https:\/\/doi.org\/10.1177\/106002809502900309","journal-title":"Ann Pharmacother"},{"issue":"7","key":"207_CR50","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.transproceed.2023.03.092","volume":"55","author":"R Thomas","year":"2023","unstructured":"Thomas R, Benken J, Belcher RM, Palmer ME, Benedetti E, Benken ST (2023) Catecholamine Vasopressor Exposure Is Associated With Early Poor Allograft Function and Adverse Events in Living Donor Kidney Transplant Recipients. Transplant Proc 55(7):1543\u20131550. https:\/\/doi.org\/10.1016\/j.transproceed.2023.03.092","journal-title":"Transplant Proc"},{"key":"207_CR51","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/1089253220949070","volume":"25","author":"JH Chow","year":"2021","unstructured":"Chow JH, Wallis M, Lankford AS, Chancer Z, Barth RN, Scalea JR, LaMattina JC, Mazzeffi MA, McCurdy MT (2021) Treatment of Renin-Angiotensin-Aldosterone System Dysfunction With Angiotensin II in High-Renin Septic Shock. Semin Cardiothorac Vasc Anesth 25:67\u201373","journal-title":"Semin Cardiothorac Vasc Anesth"},{"key":"207_CR52","first-page":"1002","volume":"134","author":"M Meersch","year":"2022","unstructured":"Meersch M, Weiss R, Massoth C, Kullmar M, Saadat-Gilani K, Busen M, Chawla L, Landoni G, Bellomo R, Gerss J et al (2022) The Association Between Angiotensin II and Renin Kinetics in Patients After Cardiac Surgery. Anesth Analg 134:1002\u20131009","journal-title":"Anesth Analg"},{"issue":"1","key":"207_CR53","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s44158-024-00186-y","volume":"4","author":"G Landoni","year":"2024","unstructured":"Landoni G, Cortegiani A, Bignami E, De Pascale G, Donadello K, Donati A, Grasselli G, Guarracino F, Monti G, Paternoster G, Tritapepe L, Girardis M (2024A 16) The use of angiotensin II for the management of distributive shock: expert consensus statements. J Anesth Analg Crit Care 4(1):56. https:\/\/doi.org\/10.1186\/s44158-024-00186-y","journal-title":"J Anesth Analg Crit Care"}],"container-title":["Journal of Anesthesia, Analgesia and Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s44158-024-00207-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s44158-024-00207-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s44158-024-00207-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T16:03:28Z","timestamp":1729181008000},"score":1,"resource":{"primary":{"URL":"https:\/\/janesthanalgcritcare.biomedcentral.com\/articles\/10.1186\/s44158-024-00207-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,17]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["207"],"URL":"https:\/\/doi.org\/10.1186\/s44158-024-00207-w","relation":{},"ISSN":["2731-3786"],"issn-type":[{"value":"2731-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,17]]},"assertion":[{"value":"20 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A waiver of informed consent was granted by the Office for the Protection of Research Subjects at the University of Illinois Chicago for this research study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"SB serves on the speaker's bureau for Innoviva, the manufacturer of synthetic angiotensin II (Giapreza).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"72"}}